Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
MaaT Pharma, based in Lyon, France, specializes in Microbiome Ecosystem Therapies (MET) TM, developing both donor-derived (MET-N) and co-cultivated (MET-C) products to restore or modulate the gut microbiome, especially in oncology and immune-related indications. Their approach emphasizes replicating the full complexity of the natural gut microbiome to achieve clinical benefit, particularly for patients with severe dysbiosis due to disease or treatment. MaaT Pharma’s MET products include both donor-derived and co-cultivated microbiome ecosystems, with a particular focus on oncology and immune modulation
Source: Company information
see also:
MaaT011
[MaaT034]…